Cargando…
RNAi-mediated knockdown of ERK1/2 inhibits cell proliferation and invasion and increases chemosensitivity to cisplatin in human osteosarcoma U2-OS cells in vitro
Osteosarcoma is the most common primary malignancy of the bone. There have been some advances in surgical and chemotherapeutic strategies, but it is still a tumor with a high mortality rate in children and young adults. Mitogen-activated protein kinase/extracellular signal regulated kinase (ERK) pat...
Autores principales: | SI, HAIPENG, PENG, CHANGLIANG, LI, JINGJING, WANG, XIQIAN, ZHAI, LIANWEN, LI, XIAOFENG, LI, JIANMIN |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3584577/ https://www.ncbi.nlm.nih.gov/pubmed/22179790 http://dx.doi.org/10.3892/ijo.2011.1303 |
Ejemplares similares
-
Knockdown of PARP-1 Inhibits Proliferation and ERK Signals, Increasing Drug Sensitivity in Osteosarcoma U2OS Cells
por: Li, Sheng, et al.
Publicado: (2016) -
TGM2 knockdown reverses cisplatin chemoresistance in osteosarcoma
por: Li, Cuiyun, et al.
Publicado: (2018) -
Secreted clusterin (sCLU) regulates cell
proliferation and chemosensitivity to cisplatin by modulating ERK1/2 signals in human
osteosarcoma cells
por: Huang, Hai, et al.
Publicado: (2014) -
RNAi-mediated knockdown of cyclooxygenase2 inhibits the growth, invasion and migration of SaOS2 human osteosarcoma cells: a case control study
por: Zhao, Qinghua, et al.
Publicado: (2011) -
Knockdown of STMN1 enhances osteosarcoma cell chemosensitivity through inhibition of autophagy
por: Wang, Zili, et al.
Publicado: (2017)